153 related articles for article (PubMed ID: 37758792)
21. Identification and verification of CCNB1 as a potential prognostic biomarker by comprehensive analysis.
Zeng Y; Fan R
Sci Rep; 2022 Sep; 12(1):16153. PubMed ID: 36167975
[TBL] [Abstract][Full Text] [Related]
22. [CDK1, CCNB1 and NDC80 are associated with prognosis and progression of hepatitis B virus-associated hepatocellular carcinoma: a bioinformatic analysis].
Li Y; Wu D; Wei C; Yang X; Zhou S
Nan Fang Yi Ke Da Xue Xue Bao; 2021 Oct; 41(10):1509-1518. PubMed ID: 34755666
[TBL] [Abstract][Full Text] [Related]
23. Expression of KIF2A, NDC80, CDK1, and CCNB1 in breast cancer patients: Their interaction and linkage with tumor features and prognosis.
Wang C; Xie X; Li W; Jiang D
J Clin Lab Anal; 2022 Sep; 36(9):e24647. PubMed ID: 35949045
[TBL] [Abstract][Full Text] [Related]
24. Cyclin B1 expression as an independent prognostic factor for lung adenocarcinoma and its potential pathways.
Li Y; Leng Y; Dong Y; Song Y; Wu Q; Jiang N; Dong H; Chen F; Luo Q; Cheng C
Oncol Lett; 2022 Dec; 24(6):441. PubMed ID: 36420081
[TBL] [Abstract][Full Text] [Related]
25. CCNB1 and CCNB2 involvement in the pathogenesis of psoriasis: a bioinformatics study.
Li AH; Chen YQ; Chen YQ; Song Y; Li D
J Int Med Res; 2022 Aug; 50(8):3000605221117138. PubMed ID: 35949173
[TBL] [Abstract][Full Text] [Related]
26. Investigation of Potential Mechanisms Associated with Non-small Cell Lung Cancer.
Shi Y; Zhu S; Yang J; Shao M; Ding W; Jiang W; Sun X; Yao N
J Comput Biol; 2020 Sep; 27(9):1433-1442. PubMed ID: 32048869
[TBL] [Abstract][Full Text] [Related]
27. Upregulation of cyclin B1 plays potential roles in the invasiveness of pituitary adenomas.
Zhao P; Zhang P; Hu W; Wang H; Yu G; Wang Z; Li C; Bai J; Zhang Y
J Clin Neurosci; 2017 Sep; 43():267-273. PubMed ID: 28601573
[TBL] [Abstract][Full Text] [Related]
28. Huanglian decoction suppresses the growth of hepatocellular carcinoma cells by reducing
Li M; Shang H; Wang T; Yang SQ; Li L
World J Gastroenterol; 2021 Mar; 27(10):939-958. PubMed ID: 33776365
[TBL] [Abstract][Full Text] [Related]
29. Upregulated cyclins may be novel genes for triple-negative breast cancer based on bioinformatic analysis.
Lu Y; Yang G; Xiao Y; Zhang T; Su F; Chang R; Ling X; Bai Y
Breast Cancer; 2020 Sep; 27(5):903-911. PubMed ID: 32338339
[TBL] [Abstract][Full Text] [Related]
30. Identification of genes associated with cancer progression and prognosis in lung adenocarcinoma: Analyses based on microarray from Oncomine and The Cancer Genome Atlas databases.
Liu W; Ouyang S; Zhou Z; Wang M; Wang T; Qi Y; Zhao C; Chen K; Dai L
Mol Genet Genomic Med; 2019 Feb; 7(2):e00528. PubMed ID: 30556321
[TBL] [Abstract][Full Text] [Related]
31. Protein phosphatase 1 regulatory subunit 3G (PPP1R3G) correlates with poor prognosis and immune infiltration in lung adenocarcinoma.
Zhuo X; Chen L; Lai Z; Liu J; Li S; Hu A; Lin Y
Bioengineered; 2021 Dec; 12(1):8336-8346. PubMed ID: 34592886
[TBL] [Abstract][Full Text] [Related]
32. CDK1 and CCNB1 as potential diagnostic markers of rhabdomyosarcoma: validation following bioinformatics analysis.
Li Q; Zhang L; Jiang J; Zhang Y; Wang X; Zhang Q; Wang Y; Liu C; Li F
BMC Med Genomics; 2019 Dec; 12(1):198. PubMed ID: 31870357
[TBL] [Abstract][Full Text] [Related]
33. Effect of CCNB1 silencing on cell cycle, senescence, and apoptosis through the p53 signaling pathway in pancreatic cancer.
Zhang H; Zhang X; Li X; Meng WB; Bai ZT; Rui SZ; Wang ZF; Zhou WC; Jin XD
J Cell Physiol; 2018 Jan; 234(1):619-631. PubMed ID: 30069972
[TBL] [Abstract][Full Text] [Related]
34.
Rong MH; Li JD; Zhong LY; Huang YZ; Chen J; Xie LY; Qin RX; He XL; Zhu ZH; Huang SN; Zhou XG
Exp Biol Med (Maywood); 2022 Mar; 247(5):395-408. PubMed ID: 34743578
[TBL] [Abstract][Full Text] [Related]
35. miR-144 negatively regulates the effect of CCNB1 protein on the biological behavior of hepatoma cells.
Lan C; Xu Z; He S; Xian L; Song Z; Bin X; Li G
Cell Mol Biol (Noisy-le-grand); 2022 Jul; 68(7):90-94. PubMed ID: 36495514
[TBL] [Abstract][Full Text] [Related]
36. CA916798 predicts poor prognosis and promotes Gefitinib resistance for lung adenocarcinoma.
He J; Lan X; Liu X; Deng C; Luo H; Wang Y; Kang P; Sun Z; Zhao L; Zhou X
BMC Cancer; 2023 Mar; 23(1):266. PubMed ID: 36959566
[TBL] [Abstract][Full Text] [Related]
37. The clinical significance of cyclin B1 (CCNB1) in invasive breast cancer with emphasis on its contribution to lymphovascular invasion development.
Aljohani AI; Toss MS; Green AR; Rakha EA
Breast Cancer Res Treat; 2023 Apr; 198(3):423-435. PubMed ID: 36418517
[TBL] [Abstract][Full Text] [Related]
38. CCNB1 is a prognostic biomarker for ER+ breast cancer.
Ding K; Li W; Zou Z; Zou X; Wang C
Med Hypotheses; 2014 Sep; 83(3):359-64. PubMed ID: 25044212
[TBL] [Abstract][Full Text] [Related]
39. Comprehensive Analysis of Cyclin Family Gene Expression in Colon Cancer.
Li J; Zhou L; Liu Y; Yang L; Jiang D; Li K; Xie S; Wang X; Wang S
Front Oncol; 2021; 11():674394. PubMed ID: 33996604
[TBL] [Abstract][Full Text] [Related]
40. Pancancer analysis of the correlations of HS6ST2 with prognosis, tumor immunity, and drug resistance.
Chen W; Li X; Jiang Y; Ni D; Yang L; Wu J; Gao M; Wang J; Song J; Shi W
Sci Rep; 2023 Nov; 13(1):19209. PubMed ID: 37932473
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
